Cargando…

Tumoral cavitation in patients with non-small-cell lung cancer treated with antiangiogenic therapy using bevacizumab

Rationale and objectives: To investigate the frequency and radiographic patterns of tumoral cavitation in patients with non-small cell lung cancer (NSCLC) treated with bevacizumab, and correlate the imaging findings with the pathology, clinical characteristics and outcome. Materials and methods: Sev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishino, Mizuki, Cryer, Sarah K., Okajima, Yuka, Sholl, Lynette M., Hatabu, Hiroto, Rabin, Michael S., Jackman, David M., Johnson, Bruce E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392782/ https://www.ncbi.nlm.nih.gov/pubmed/22743083 http://dx.doi.org/10.1102/1470-7330.2012.0027

Ejemplares similares

Interstitial lung abnormality in stage IV non-small cell lung cancer: A validation study for the association with poor clinical outcome
por: Araki, Tetsuro, et al.
Publicado: (2019)

Tumor volume dynamics and tumor growth rate in ALK-rearranged advanced non-small-cell lung cancer treated with crizotinib
por: Nishino, Mizuki, et al.
Publicado: (2020)

M1b Disease in the 8th Edition of TNM Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcome
por: Park, Hyesun, et al.
Publicado: (2019)

Immune-Related Thyroiditis in Patients with Advanced Lung Cancer Treated with Immune Checkpoint Inhibitors: Imaging Features and Clinical Implications
por: Park, Hyesun, et al.
Publicado: (2023)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
por: Datar, Saumil, et al.
Publicado: (2020)

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
por: Ricciuti, Biagio, et al.
Publicado: (2019)

Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy
por: Peng, Yu, et al.
Publicado: (2018)

BRAF-Mutant Pulmonary Langerhans Cell Histiocytosis Mimicking Recurrence of Early-Stage KRAS-Mutant Lung Adenocarcinoma
por: Alden, Stephanie L., et al.
Publicado: (2020)

Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients
por: Nishino, Mizuki, et al.
Publicado: (2016)

Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study
por: Hida, Tomoyuki, et al.
Publicado: (2021)

Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging Characteristics
por: Nishino, Mizuki, et al.
Publicado: (2022)

Incidence of Brain Metastases and Preliminary Evidence of Intracranial Activity With Sotorasib in Patients With KRAS(G12C)-Mutant Non–Small-Cell Lung Cancer
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

Standard-dose vs. low-dose CT protocols in the evaluation of localized lung lesions: Capability for lesion characterization—iLEAD study()
por: Kubo, Takeshi, et al.
Publicado: (2016)

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome
por: Nishino, Mizuki, et al.
Publicado: (2014)

Low dose chest CT protocol (50 mAs) as a routine protocol for comprehensive assessment of intrathoracic abnormality
por: Kubo, Takeshi, et al.
Publicado: (2016)

Advances in antiangiogenic treatment of small-cell lung cancer
por: Lu, Hongyang, et al.
Publicado: (2017)

Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy
por: Xu, Hui, et al.
Publicado: (2015)

A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles
por: Sousa, Flávia, et al.
Publicado: (2017)

Anterior mediastinal masses in the Framingham Heart Study: Prevalence and CT image characteristics
por: Araki, Tetsuro, et al.
Publicado: (2015)

Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents
por: García-Alfonso, Pilar, et al.
Publicado: (2015)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

Malignant Cavitation of the Lung
Publicado: (1930)

Special Issue: Chest Imaging 2021
por: Hatabu, Hiroto
Publicado: (2020)

Projected lung areas using dynamic X-ray (DXR)
por: Hino, Takuya, et al.
Publicado: (2020)

Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis
por: Mollard, Severine, et al.
Publicado: (2017)

Treatment of rhodamine B with cavitation technology: comparison of hydrodynamic cavitation with ultrasonic cavitation
por: Ye, Yu-Fang, et al.
Publicado: (2021)

Cavitation
por: Young, F Ronald
Publicado: (1999)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

Risk of bleeding associated with antiangiogenic monoclonal antibodies bevacizumab and ramucirumab: a meta-analysis of 85 randomized controlled trials
por: Xiao, Bingkun, et al.
Publicado: (2018)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Lung cavitation in COVID-19 pneumonia
por: Ammar, A., et al.
Publicado: (2021)

A comparison of visual and quantitative methods to identify interstitial lung abnormalities
por: Kliment, Corrine R., et al.
Publicado: (2015)

Subsolid pulmonary nodules: Controversy and perspective
por: Hammer, Mark M., et al.
Publicado: (2020)

Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
por: Williamson, Drew F. K., et al.
Publicado: (2022)

Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs
por: Coschignano, Maria Antonietta, et al.
Publicado: (2021)

Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
por: Sun, Qi, et al.
Publicado: (2022)

Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells
por: Sethi, Aisha, et al.
Publicado: (2011)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

Predictors of Lesion Cavitation After Recent Small Subcortical Stroke
por: Gattringer, Thomas, et al.
Publicado: (2019)

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
por: Ulahannan, Susanna V, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_dthcari0il6lsbtvs4h67jln56